Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria

BACKGROUND: In many endemic areas, Plasmodium vivax malaria is predominantly a disease of young adults and children. International recommendations for radical cure recommend fixed target doses of 0.25 or 0.5 mg/kg/day of primaquine for 14 days in glucose-6-phosphate dehydrogenase normal patients of...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Walter Robert, Hoglund, Richard M., Peerawaranun, Pimnara, Nguyen, Thuy Nhien, Hien, Tran Tinh, Tarantola, Arnaud, von Seidlein, Lorenz, Tripura, Rupam, Peto, Thomas J., Dondorp, Arjen M., Landier, Jordi, H.Nosten, Francois, Smithuis, Frank, Phommasone, Koukeo, Mayxay, Mayfong, Kheang, Soy Ty, Say, Chy, Neeraj, Kak, Rithea, Leang, Dysoley, Lek, Kheng, Sim, Muth, Sinoun, Roca-Feltrer, Arantxa, Debackere, Mark, Fairhurst, Rick M., Song, Ngak, Buchy, Philippe, Menard, Didier, White, Nicholas J., Tarning, Joel, Mukaka, Mavuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427859/
https://www.ncbi.nlm.nih.gov/pubmed/34503519
http://dx.doi.org/10.1186/s12936-021-03886-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427859/
https://www.ncbi.nlm.nih.gov/pubmed/34503519
http://dx.doi.org/10.1186/s12936-021-03886-w

Ejemplares similares